{"text": "bmy transcend fl and transcend nhl 001 studies of breyanzi in relapsed or refractory follicular lymphoma and mantle cell lymphoma meet primary endpoint of overall response rate"}
{"text": "auph teva bmy nvs amgn after lowering 2023guidance i expect nothing less frm pg than to beat q4 22 4th may amp rise again to original trgt 140m especially if asking for 4more million shares to grant oldest trick in world that management do to justify opt bonuses rsu seen it"}
{"text": "immatics imtx announces first bristol myers squibb bmy opt in of tcr t candidate from ongoing multi target strategic collaboration 15m opt in fee for imtx up to 505m program incl opin milestones tiered royalties"}
{"text": "bmy fda accepts for priority review sbla and ema validates application for reblozyl as first line treatment of anemia in adults with lower risk myelodysplastic syndromes mds pdufa 08 23 23"}
{"text": "merck edged out rivals including abbvie and bristol myers to speedily ink its 10 8 billion deal for prometheus according to new deets in a filing sources familiar w the matter mrk abbv bmy rxdx my latest via"}
{"text": "bristol myers squibb bmy s transcend fl and transcend nhl 001 studies of breyanzi lisocabtagene maraleucel in r r fl and mcl meet primary endpoint of orr"}
